ABIRATERONE ACETATEus fda inspected manufacturing plant
SAMPLES, WORKING STANDARDS AND IMPURITIES AVAILABLE
THERAPEUTIC INDICATION: ONCOLOGY
For the treatment of metastatic castration resistant prostate cancer.
Originator: JOHNSON & JOHNSON
Originator product: ZYTIGA®
Core patent exclusivities : US 04/2015; Europe 09/2022
- Manufactured in China
- API validated and commercially available
- US FDA-inspected manufacturing plant
- Samples, working standards and impurities are available
- Active US-DMF and ASMF available
This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.